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THE aim of this study was to investigate the effects of
interferon-T and -
(IFN-T, -), interleukin-4 and -10 (IL-4,
-lO)and Hpopolysaccharide (LPS) on the metabolism and
composition ofphospholipid fatty acids in macrophages.
Murine J774.2 macrophages were incubated with
radiolabelled fatty acids and the appropriate stimulus and
the incorporation and composition of the phospholipid
classes was determined. IFN-T and IL-4 specifically stimu-
lated enhanced incorporation of [14C]-finoleic acid into
the phosphatidytethanolamine fraction. IL-4 (in contrast
to IFN-/ and LPS) reduced incorporation of P4C]-
arachidonic acid into phosphatidylinositol. Incubation of
J774.2 cells with linoleic acid significantly increased
TNFx and nitric oxide production; arachidonic acid en-
hanced TNFx production but reduced nitric oxide pro-
duction. It is concluded that IFN-T, IL-4 and IL-IO may
differentially regulate macrophage activation via effects
on the metabolism of polyunsaturated fatty acids.
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Introduction
Bacterial endotoxin (lipopolysaccharide, LPS) is an
important inducer of the sepsis syndrome, a rapidly
fatal illness which remains a major cause of morbidity
and mortality in the modern medical centre. Some
patients become hypersusceptible to the lethal ef-
fects of endotoxin, although the mechanism for this
sensitivity remains poorly understood. Animal mod-
els of endotoxic shock have revealed that concomi-
tant bacterial or mycobacterial infections greatly in-
crease susceptibility to the lethal effects of
endotoxin and that antibody to tumour necrosis
factor-0t (TNF00 or interferonq, (IFN-T) are benefi-
cial.2, It is becoming increasingly clear that IFN-T is
an important mediator of hypersensitivity to
endotoxin. IFN-T has been shown to induce expres-
sion of LPS binding sites on the cell surface of lung
macrophages which lack binding sites for LPS. Fur-
thermore, IFN-T has been identified as the mediator
of Propionibacterium acnes-induced LPS
hypersensitivity in mice.
Macrophages are primary target cells for endotoxin
and by production of endogenous mediators such
as superoxide anion, nitric oxide, cytokines
(interleukin-1, -6, -8 (IL-1, -6, -8) and TNF) and lipid
mediators (for example, prostaglandins and
leukotrienes), contribute to the pathophysiology of
endotoxic shock.
Infection of mice with BeG results in increases in
the ratio of polyunsaturated:saturated fatty acids in
vivo in peritoneal macrophages and it has recently
been shown that IFN-T is able to increase
macrophage phospholipid polyunsaturated in
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vitro. 6,7 It is believed that this could be a possible
mechanism of endotoxin sensitivity and we have
demonstrated that IFN-T and exogenous polyunsatu-
rated fatty acids increase binding of LPS to mouse
macrophages. Metabolic studies are consistent with
this and have demonstrated that IFN-T may act as
sensitizer to the effects of endotoxin by increasing
the linoleic acid metabolism of macrophages and it
has been proposed that IFN-T could prime these cells
for a heightened response to LPS.
T-helper Type 1 and 2 cells are classified according
to the pattern of lymphokines they produce.
1 Inter-
feronq, and IL-2 are produced by Thl cells, and IL-
4, IL-5 and IL-10 by Th2 cells. 11 Since these two
subsets are known to be functionally distinct and
frequently act antagonistically1’-15 we wish to exam-
ine the effects of IL-4 and IL-10 on the phospholipid
composition of macrophage cells which are believed
to be of paramount importance in the sepsis syn-
drome. Thus, these interleukins would form a com-
parison to the IFN-T effects observed previously. In
addition, IFN-]3 which has been shown not to play a
significant role in the interaction of macrophages
with endotoxin was included in the experiments to
confirm the specificity of any effects on fatty acid
metabolism. The data reported here provide further
evidence for the role of linoleate in macrophage
phospholipids in mediating sensitivity to endotoxin.
Materials and Methods
Reagents: All reagents were purchased from Sigma
Chemical Company Ltd, Poole, UK, unless stated
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otherwise. 14C-labelled arachidonic, linoleic and
stearic acids (50-60 mCi/mmol) were supplied by
Amersham International plc, Aylesbury, UK. IFNq,,
IL-4 and IL-10 were purchased from Genzyme, Kent,
UK.
Cell culture:
Growth medium. Cells were cultivated in
Dulbecco’s modification of Eagle’s medium (DMEM)
which had been supplemented with 10% foetal calf
serum (FCS) and an antibiotic solution containing
100 units/ml penicillin and 100 g/ml streptomycin.
Cell line. The murine (BALB/C) tumour
monocyte-macrophage J774.2 (European Collection
of Animal Cell Cultures, Salisbury, Wiltshire, UK),
was the cell line used in the course of this investiga-
tion. These cells were maintained in DMEM supple-
mented as described above.
Pretreatment with IFN-{, IFN-, LPS and
interleukin-4. Exposure of J774.2 cells (1 x 106) to
murine recombinant IFN-, and IFN-I (50 U/ml), 10
btg/ml Escherichia coli Olll:B4 LPS, and murine
recombinant IL-4 and IL-10 (50 U/ml) was carried out
for 18 h at 37C, in a humidified incubator containing
5% CO,. At the end of the incubation period the cells
were dislodged by gentle agitation, washed three
times with DMEM and collected by centrifugation at
1 000 xg for 5 min and finally resuspended in DMEM
Preparation ofammonium salts of the radiolabelled
fatty acids: To aid solubility of the radiolabelled fatty
acids, they were converted into their ammonium salts
as follows. The fatty acids were supplied in either
ethanol or toluene and as a first stage the solvent was
evaporated under a stream of nitrogen. The ammo-
nium salt of the fatty acid was then prepared by
incubating the fatty acids in 0.2 ml of 2 M ammonia
solution at 60-70C under nitrogen for 30 min. The
solution was evaporated to dryness under a stream
of nitrogen and the resulting ammonium salts were
resuspended in a known volume of growth medium.
Incorporation ofl4C-fatty acids: Cells were incubated
in the presence of 0.2 t.tCi of the radiolabelled fatty
acids (ammonium salt) with or without IL-4 and IL-
l0 for 18 h at 37C in a humidified CO,. incubator.
After the appropriate incubation time, the cells were
centrifuged at 1 000 x g for 3 min, washed in 10 ml
phosphate buffered saline and collected by centrifu-
gation at I 000 x g for 3 min and finally resuspended
in 1 ml deionized water and sonicated in an ultra-
sonic water bath at maximum power. Once complete
lysis of the cells had been achieved (verified by light
microscopy) the cells were processed for
phospholipid extraction.
Extraction ofphospholipids: The method of Garbus et
al. 16 was used since it enabled quantitation of all
phospholipid classes. To 1 ml of the lysed cell sus-
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pension 3.75 ml chloroform/methanol (1:2 v/v) was
added, mixed thoroughly and left at room tempera-
ture for 30 min. Then chloroform (1.25 ml) and 2 M
KCl in 0.5 M phosphate buffer, pH 7.4 (1.25 ml) were
added and the solution mixed thoroughly again. The
chloroform phase containing the extracted
phospholipids was dried in a stream of nitrogen and
then subjected to thin layer chromatography.
Thin layer chromatography: The dried phos-
pholipids were dissolved in 30 I.tl chloroform,
spotted onto silica gel G plates (BDH) and
chromatographed in a solvent system consisting of
chloroform:methanol:acetic acid:water (50:30:8:1, by
volume). Phospholipid standards were
chromatographed on separate lanes. The resolved
radiolabelled phospholipids were located by expo-
sure to iodine vapour, and the appropriate areas
scraped off into scintillation vials for .radioactivity
determination. Phospholipids to be processed for gas
liquid chromatography (GLC) were located under UV
light after staining with 8-anilino-1-
naphthalenesulphonic acid, scraped off into sealable
tubes.
Analysis of lipid fatty acids by GLC: Phospholipid
and neutral lipid fractions were scraped from the
silica gel G plates and methylated with 1 ml 2.5%
H2SO in methanol in sealed tubes at 70C for 2 h.
The reaction was stopped by addition of 2.5 ml of 5%
NaC1 and the methyl esters extracted three times with
petroleum ether (60-80C fraction). Heneiconsanoic
acid (21:0) was used as an internal standard and the
samples were analysed using a Perkin Elmer 8600 gas
chromatograph equipped with a flame ionization
detector. A fused silica WCOT 50 m x 0.25 mm i.d.
column coated with CP-Sil 88 was used. The column
temperature was ramped from 205C to 255C and
the injector and detector temperatures were 275C
and 305C respectively. Carrier gas (nitrogen) was
used at 20 psi. Peak areas, retention times and re-
sponse factors were automatically computed, the
yields being calculated using the 21:0 internal stand-
ard.
Determination ofTNF release: The Factor-Test-XTM
Mouse TNF ELISA kit was used to determine the
concentration of TNF0t released by J774.2 cells in the
presence and absence of interferonq, or -[. Briefly,
100 l.tl of the culture supernates were centrifuged at
1 000 g for 2 min in order to separate any debris
from the supernates and applied to a 96-well
microtitre plate precoated with monoclonal anti-m-
TNF0t in order to capture any mTNF0t present in the
samples. The plate was sealed and incubated at 37C
for 2 h. The plate was then washed to remove
unbound material, and a peroxidase-conjugated
polyclonal anti-mTNF (HRP-conjugate, which binds
to captured mTNF0t, was added and the plate wasMacrophage activation andfatty acids
sealed and incubated for 1 h at 37C. The plate was
washed again to remove unbound material and a
substrate solution was added which initiates a
peroxidase catalysed colour change. The plate was
incubated at room temperature for 10 min, after
which time a stop solution was added which stops
the colour change, by acidification. The absorbance
was measured at 540 nm and this was proportional
to the concentration of TNF{x present in standards or
samples. A standard curve was obtained by plotting
the concentrations of TNF0t standards vs. their result-
ing absorbances and the mTNF0t concentrations in
experimental samples were then determined using
the standard curve.
Nitrite assay: One hundred t.tl of the culture
supernates were mixed with an equal volume
of Griess reagent which consisted of 1% sulfanil
amide, 0.1% N-(1-naphthyl)-ethylenediamine
dihydrochloride and 2.5% phosphoric acid and left in
the dark for 20 min at room temperature. A Titertek
multiscan microtitre plate reader was used for the
determination of the absorbance at 540 nm, which is
proportional to the concentration of nitrite in the
medium.
Results
The effects of interferons or LPS on the uptake of
radiolabelled exogenous fatty acids by macrophages
have recently been reported, and in this investigation
we examined the effects of IL-4 and IL-10, whose
biological actions are reported to contrast with some
of the activating properties of IFN-T on J774.2 cells.
Uptake of 14C-linoleate and 14C-arachidonate into the
major lipid classes (phosphatidylcholine (PC), PE,
phosphatidylinositol (PI), and neutral lipid (NL) frac-
tions) from macrophages were examined after
pretreatment.
Figure la shows that IL-4 induces a statistically
significant increase in the incorporation of 4C-
linoleic acid into the phosphatidylethanolamine (PE)
(p < 0.01 compared with control cells) fraction of the
macrophages. The phosphatidylcholine (PC) and
phosphatidylinositol (PI) fractions showed reduced
incorporation (p < 0.05 vs. control cells) of this fatty
acid. Figure lb shows that IL-4 induces a small but
statistically significant increase in the incorporation
of 14C-arachidonic .acid into the PC and a reduced
incorporation into the PI fraction of the J774.2 cell
membrane phospholipids.
In contrast to IL-4, IL-10 did not affect the incorpo-
ration of linoleic acid into the PE fraction. However,
there was a statistically significant reduction in the
incorporation of this fatty acid into the PC fraction.
Furthermore, IL-10 induced an increase in the uptake
of 4C-arachidonic acid into the PE fraction and a
decrease in the PI (data not shown).
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FIG. 1. Effect of IL-4 on the uptake of (a) 14C-linoleic acid and (b) 14C-
arachidonic acid into the PC, PI, PE and NL fractions of J774.2 cell
membrane phospholipids. Cells were incubated with 0.2 lCi of the
radiolabelled fatty acids for 18 h at 37C with and without IL-4. Error bars
represent +/- standard error of the means. (*p < 0.05; **p< 0.01 vs. controls). ,, control; l---], IL-4.
We were particularly interested in the cytokines
that induce increases in the linoleate proportions of
the PE fractions of J774.2 cell membrane
phospholipids. Therefore, the effects of IFN-7, IFN-
[, LPS and IL-4 on the endogenous linoleate,
arachidonate and stearic acid content were exam-
ined.
Figure 2 shows the effects of IFN-, LPS, IL-4 and
IFN-7 on the composition of the polyunsaturated
fatty acids, arachidonic acid (2a), linoleic acid (2b)
and the saturated fatty acid, stearic acid (2c) of the PE
fraction of the membrane phospholipids of J774.2
cells. It can be seen that IFN-7 and LPS induce
increases in the content of arachidonic acid (Fig. 2a)
in comparison with control cells (p < 0.05 vs. control
cells for LPS treatment). The increases were 15% and
27.7%, respectively, for IFN-T or LPS treatment. In
contrast, IFN-[-pretreated cells showed a 37% de-
crease in the arachidonic acid content and IL-4
showed a 25% decrease (p < 0.05).
Figure 2b shows the percentage (by weight) of
linoleic acid in the PE fraction of the membrane
phospholipids of control cells and of pretreated cells.
LPS, IFN-T and IL-4 stimulated significant increases in
the linoleic acid content of these cells in comparison
with control cells. The greatest increases were in-
duced by LPS and IL-4 which showed increases of
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173% (p < 0.01 vs. control cells) and 212% (p < 0.01
vs. control cells) respectively. IFN-, induced an in-
crease of 101% (p < 0.01 vs. control cells). In contrast,
IFN-3 did not increase the content of linoleic acid.
As it is believed that the polyunsaturated compo-
nents of the plasma membrane play an important role
in predisposing to endotoxin sensitivity,
17 stearic acid
composition was used as a control. IFN-T, IL-4, LPS
and IFN-]3-pretreatment of the cells all result in a
reduction in the percentage composition of stearic
acid, in comparison with control cells (Fig. 2c). The
greatest reduction in the content of this saturated
fatty acid is seen in IFNq,, LPS and IL-4-pretreated
cells, which showed decreases of 68%, 48% and 38%
respectively (p < 0.001 vs. control cells for all three).
IFN-[3 caused a 24% reduction in the composition of
stearic acid in the PE fraction of these cells (p < 0.05).
Thus, these effects are in marked contrast to the
differential effects of mediators on linoleate levels in
J774.2 cells.
Figure 3 shows the results of the ELISA assay for
TNF0t release in control cells and in cells
preincubated with arachidonic and linoleic acids for
18 h and subsequently incubated with LPS for 4 h.
Control cells produced very little TNF0t but when
they were incubated with LPS for 4 h there was a
great increase in the release of this cytokine (p <
0.00001 vs. control cells). Cells which had been
preincubated with linoleic acid and then with LPS for
4 h showed increased TNF0t release (p < 0.05 vs.
control cells which were subsequently incubated
with LPS). Although arachidonic acid pretreatment
resulted in a slight increase in TNF0t release, the
increase was not statistically significant. Cells
preincubated with these fatty acids without subse-
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FIG. 2. Fatty acid compositions (% by weight) of control, IFN-7-pretreated,
IFN-l-pretreated, and LPS pretreated J774.2 cells for (a) arachidonic acid;
(b) linoleic acid and (c) stearic acid. Cells (1 x 106/ml) were pretreated with
either 50 U/ml IFN-l, or IFN-I], or with 10 U/ml LPS for 18 h at 37C. Error
bars represent standard error of the means. (*p < 0.05; **p < 0.01; ***p
< 0.001 vs. control cells).
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FIG. 3 TNF release in control cells, and in control cells and cells
preincubated with arachidonic (AA) and linoleic acids (LA) (50 l.tg/ml) for 18
h at 37C which were subsequently incubated with LPS (100 ng/ml) for 4
h at 37C. Error bars represent standard error of the means. (*p < 0.05
vs. LPS-treated cells; tp < 0.00001 vs. control cells).
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quent incubation with LPS did not show increased
production of TNF.
Figure 4 shows the release of nitric oxide (meas-
ured as nitrite) from control cells and from cells
pretreated with IFN-y, IFN-[ and IL-4, linoleic and
arachidonic acids with or without LPS. IFN-y and LPS
on their own induced increases in the production of
nitric oxide (p < 0.00001 vs. control cells for both) but
this increase was much more marked in cells
preincubated with IFN-y in the presence of LPS. IFN[
did not have any effect on the production of nitric
oxide. IL-4, on the other hand, induced a statistically
significant inhibition in the LPS-mediated production
of nitric oxide (p < 0.05 vs. LPS treated cells).
When cells were incubated with arachidonic acid
and LPS together there was a slight but statistically
significant decrease in nitric oxide production (p <
0.05 vs. LPS treated cells). Linoleic acid with LPS
induced a statistically significant increase in nitric
oxide production (p < 0..01 vs. LPS treated cells).
When the cells were preincubated with linoleic acid
or arachidonic acid alone there was no change in
nitric oxide levels (data not shown).
Discussion
It has previously been reported that IFN-y may
exert at least some of its effects on macrophage cells
by increasing the polyunsaturation of the fatty acyl
side chains of membrane phospholipids. These may
be important in the subsequent interaction of
macrophages with endotoxin. This study has shown
that LPS increases the content of the polyunsaturated
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FIG. 4. Production of nitric oxide (measured as nitrite) from control cells and
from cells pretreated with IFN-y, IFN- and IL-4, arachidonic (AA) and
linoleic acids (LA) with and without 100 ng/ml LPS. Cells (1 x 106/ml) were
preincubated with the cytokines at a concentration of 50 U/ml, and with 50
lg/ml of arachidonic or linoleic acids for 18 h at 37C. Error bars represent
standard error of the means. (*p < 0.00001 vs. control cells; p < 0.05
and :I:P < 0.01 both vs. LPS-treated cells). I-I, without LPS; I, with LPS.
fatty acids, arachidonate and linoleate and decreases
the content of the saturated fatty acid, stearate, in the
membrane PE fraction. Interestingly, LPS-pretreated
cells showed greater increases in the content of
unsaturated fatty acids and greater decreases in the
content of the saturated fatty acid, in comparison
with IFN-y pretreated cells.
In this study it was found that IL-4 acts similarly to
IFN-y and LPS in increasing the linoleic acid and
decreasing the stearic acid content of J774.2 cells.
IFN-[ caused a decrease in the content of
arachidonic acid (Fig. 2a) and a slight increase in the
linoleic acid (Fig. 2b) content of PE in J774.2 cells.
The effects of IFN-[ which were found for J774.2
cells are in marked contrast to those for IFN-y.
It has recently been reported that IFN-[ induces a
significant decrease in membrane lipid bilayer fluid-
ity of J774.2 cells and the decreased fluidity is in
keeping with the slightly decreased incorporation of
14C-linoleic acid in these macrophage membrane
phospholipids.
18 IFN-[ has also been reported to
increase the saturated fatty acid content of mouse
sarcoma S-180 cells. 19 These are in agreement with
the effects of IFN-[ that were found for murine
macrophages.
It has been found that IL-4 acted similarly with LPS
and IFN-y in increasing the incorporation of 14C-
linoleic acid into the PE fraction of J774.2 cell mem-
branes. However, IFN-y induced increases in incor-
poration of this fatty acid into all fractions of mem-
brane phospholipids, whereas IL-4 induced de-
creases in the PC and PI fractions. The effects of IL-
l0 were not examined since this cytokine did not
stimulate uptake of 14C-linoleic acid.
The fact that IFN-y and LPS both increase the
content of linoleic and arachidonic acids and IFN-
does not, and that IFN-y priming can lead to en-
hanced LPS binding which can be mimicked by
linoleic and arachidonic acids but not by interferon-
[ also supports our hypothesis that a possible
mechanism for IFN-y-induced LPS hypersensitivity
involves fatty acid changes in the membrane
phospholipids.
The consequence of these lipid changes are that
IFN-y increases membrane fluidity and in so doing
can render greater molecular mobility of membrane
receptors. This results in increased LPS binding to
IFN-y-pretreated macrophages and also greater ex-
pression of CD-14 (unpublished results) recently
reported to be a receptor for complexes of LPS and
LPS-binding protein.
Increasing evidence suggests that macrophage ac-
tivation and cytokine production can be regulated by
polyunsaturated fatty acids (PUFA). Thus, n-3 PUFA
have been shown to suppress the ability of
macrophages to produce IL-1, IL-6 and TNF, but the
n-6 PUFA, typified by linoleic acid, can enhance their
production.,. The oxidative metabolites of PUFA
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(eicosanoids) have been shown to regulate
macrophage inflammatory reactions including
cytokine synthesis. Among the arachidonic acid
metabolites, prostaglandin E2 (PGE2) has been found
to have important feedback actions on macrophages.
In many cases PGE provides a negative feedback
signal for the production of cytokines such as TNF(X21
and IL-1.22 Interestingly, it has been suggested that
IFN-T can down-regulate PGE production, perhaps
via a decrease in cyclooxygenase activity, and this
enhances the production of the pro-inflammatory
cytokines. 23
Several recent studies provide evidence that
lipoxygenases are involved in the activation of
mononuclear phagocytes. 24 It is well recognized that
TNF mediates many of the lethal effects of endotoxin
and recently 13-hydroxylinoleic acid has been re-
ported to be of functional importance in TNF forma-
tion by macrophages treated with LPS. 25 Pretreatment
of macrophages with IFN-T and IL-4 results in LPS-
induced TNFot release and it is believed that this
could be as a result of increases in the linoleic acid
content of these macrophages.
From our results it can be seen that IL-4 induces
increases in the linoleic acid but not the arachidonic
acid content in J774.2 macrophage membranes. IL-4
decreases LPS-induced nitric oxide production but
increases LPS-induced TNFot production, in agree-
ment with recent findings. 26 Therefore, induction of
TNFz in this case is not due to increases in endo-
genous arachidonic acid and suggests that linoleic
acid may play a significant role in TNFz production
by macrophages. Induction of nitric oxide release, on
the other hand, may require the presence of both
endogenous arachidonic and linoleic acids.
Linoleic acid, therefore, may be an important me-
diator in LPS-induced responses in macrophages,
and IFN-T and IL-4, by increasing the linoleate con-
tent in phospholipids, could prime these cells for a
heightened response to LPS.
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